Eli Lilly and Company
(NYSE:LLY)
$598.05
9.78 (1.66%)
Open: 12:15 PM
LLY Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
LLY Stock Price Today
Eli Lilly and Company (LLY) stock rallied over 1.47% intraday to trade at $597.91 a share on NYSE. The stock opened with a loss of -4.29% at $563.01 and touched an intraday high of $570.81, rising 1.64% against the last close of $588.27. The Eli Lilly and Company in stock market went to a low of $556.64 during the session.
LLY Stock Snapshot
$588.27
Prev. Close
567.73 Billion
Market Cap
$556.64
Day Low
$563.01
Open
N/A
Number of Shares
$570.81
Day High
110.39
P/E ratio
5.42
EPS (TTM)
2.92
Cash Flow per Share
N/A
Free Float in %
12.48
Book Value
1916181.00
Volume
LLY Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.32
Sales or Revenue$32.07 Billion
5Y Sales Change4.79%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryDrug Manufacturers—General
About Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Peers
Frequently Asked Questions
What is the current Eli Lilly and Company (LLY) stock price?
Eli Lilly and Company (NYSE: LLY) stock price is $597.91 in the last trading session. During the trading session, LLY stock reached the peak price of $570.81 while $556.64 was the lowest point it dropped to. The percentage change in LLY stock occurred in the recent session was 1.47% while the dollar amount for the price change in LLY stock was $8.66.
LLY's industry and sector of operation?
The NYSE listed LLY is part of Drug Manufacturers—General industry that operates in the broader Healthcare sector. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Who are the executives of LLY?
Mr. Alonzo Weems
Senior Vice President and Chief Ethics & Compliance Officer
Mr. David A. Ricks
Chairman, Chief Executive Officer & Pres
Dr. Daniel M. Skovronsky M.D., Ph.D.
Senior Vice President, Chief Scientific & Medical Officer and Pres of Lilly Research Labs
Ms. Leigh Ann Pusey
Senior Vice President of Corporation Affairs & Communications
How LLY did perform over past 52-week?
LLY's closing price is 0.51% higher than its 52-week low of $309.2 where as its distance from 52-week high of $629.97 is -0.01%.
How many employees does LLY have?
Number of LLY employees currently stands at N/A. LLY operates from Lilly Corporate Center, Indianapolis, IN 46285, US.
Link for LLY official website?
Official Website of LLY is: https://www.lilly.com
How do I contact LLY?
LLY could be contacted at phone #317 276 2000 and can also be accessed through its website. LLY operates from Lilly Corporate Center, Indianapolis, IN 46285, US.
How many shares of LLY are traded daily?
LLY stock volume for the day was 1916181.00 shares. The average number of LLY shares traded daily for last 3 months was 3.24 Million.
What is the market cap of LLY currently?
The market value of LLY currently stands at $567.73 Billion with its latest stock price at $597.91 and N/A of its shares outstanding.